Doutremepuich C - Search Results

1

Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of ASA at ultra low doses?

Lalanne MC, de Seze O, Doutremepuich C, Belon P. Lalanne MC, et al. Among authors: doutremepuich c. Thromb Res. 1991 Aug 15;63(4):419-26. doi: 10.1016/0049-3848(91)90228-o. Thromb Res. 1991. PMID: 1754994

2

Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H. activity in thrombosis? (Part II).

Doutremepuich F, Lalanne MC, Slimani M, Doutremepuich C. Doutremepuich F, et al. Among authors: doutremepuich c. Thromb Res. 1992 May 15;66(4):445-9. doi: 10.1016/0049-3848(92)90293-j. Thromb Res. 1992. PMID: 1329259

3

Some hemostatic and hemorheological disorders in auditory and vestibular impairments.

Lalanne MC, Doutremepuich C, Boj F, Traissac L, Quichaud F. Lalanne MC, et al. Among authors: doutremepuich c. Thromb Res. 1992 Jun 15;66(6):787-91. doi: 10.1016/0049-3848(92)90055-f. Thromb Res. 1992. PMID: 1519237 No abstract available.

4

In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages.

Lalanne MC, Ramboer I, de Sèze O, Doutremepuich C. Lalanne MC, et al. Among authors: doutremepuich c. Thromb Res. 1992 Jan 1;65(1):33-43. doi: 10.1016/0049-3848(92)90223-w. Thromb Res. 1992. PMID: 1604441

5

The role of essential vitamins in the development of thrombosis and hemorrhage--an experimental study.

Puyal C, Doutremepuich F, Lalanne MC, Doutremepuich C. Puyal C, et al. Among authors: doutremepuich c, doutremepuich f. Thromb Res. 1992 Jan 1;65(1):45-54. doi: 10.1016/0049-3848(92)90224-x. Thromb Res. 1992. PMID: 1604442

6

Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H activity in thrombosis? (Part I).

Doutremepuich C, Lalanne MC, Doutremepuich F, Francois C, Dosque JP, Sassoust G. Doutremepuich C, et al. Among authors: doutremepuich f. Thromb Res. 1991 Jul 1;63(1):13-9. doi: 10.1016/0049-3848(91)90265-x. Thromb Res. 1991. PMID: 1658961

7

Effects of immuno-potent drugs and their association with an unfractionated heparin on an experimental venous thrombosis.

Puyal C, Lalanne MC, Doutremepuich C. Puyal C, et al. Among authors: doutremepuich c. Thromb Res. 1991 Oct 15;64(2):263-72. doi: 10.1016/0049-3848(91)90125-g. Thromb Res. 1991. PMID: 1811344

8

What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall?

Lalanne MC, Doutremepuich C, de Sèze O, Belon P. Lalanne MC, et al. Among authors: doutremepuich c. Thromb Res. 1990 Nov 1;60(3):231-6. doi: 10.1016/0049-3848(90)90184-e. Thromb Res. 1990. PMID: 2084952 No abstract available.

9

Modifications of biological activities of heparin and fraxiparine induced by the size and the age of a thrombus. Experimental study.

Doutremepuich C, Llido S, Lalanne MC, Doutremepuich F. Doutremepuich C, et al. Among authors: doutremepuich f. Thromb Res. 1990 Aug 1;59(3):439-47. doi: 10.1016/0049-3848(90)90405-2. Thromb Res. 1990. PMID: 2237821

10

Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation.

Doutremepuich C, de Sèze O, Le Roy D, Lalanne MC, Anne MC. Doutremepuich C, et al. Haemostasis. 1990;20(2):99-105. doi: 10.1159/000216114. Haemostasis. 1990. PMID: 2347518 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters